BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35525225)

  • 1. L1 cell adhesion molecule high expression is associated with poor prognosis in surgically resected brain metastases from lung adenocarcinoma.
    Wang JW; Wang SQ; Wu ZY; Liu Q; Yuan Q; Cai HQ; Wan JH
    Clinics (Sao Paulo); 2022; 77():100040. PubMed ID: 35525225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis.
    Feng X; Guan N; Xu E; Miao Y; Li C
    Dis Markers; 2021; 2021():8585633. PubMed ID: 35003395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L1CAM expression in either metastatic brain lesion or peripheral blood is correlated with peripheral platelet count in patients with brain metastases from lung cancer.
    Wang JW; Wang HL; Liu Q; Hu K; Yuan Q; Huang SK; Wan JH
    Front Oncol; 2022; 12():990762. PubMed ID: 36387224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.
    Tischler V; Pfeifer M; Hausladen S; Schirmer U; Bonde AK; Kristiansen G; Sos ML; Weder W; Moch H; Altevogt P; Soltermann A
    Mol Cancer; 2011 Oct; 10():127. PubMed ID: 21985405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
    Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
    JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression.
    Park S; Cho Y; Kim HS
    Anticancer Res; 2023 Oct; 43(10):4559-4571. PubMed ID: 37772557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas.
    Trietsch MD; Oonk MH; Hawinkels LJ; Bor R; van Eendenburg JD; Ivanova Z; Peters AA; Nijman HW; Gaarenstroom KN; Bosse T
    Oncotarget; 2016 May; 7(18):26192-205. PubMed ID: 27028855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
    Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
    Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L1CAM expression in colorectal cancer identifies a high-risk group of patients with dismal prognosis already in early-stage disease.
    Tampakis A; Tampaki EC; Nonni A; Tsourouflis G; Posabella A; Patsouris E; Kontzoglou K; von Flüe M; Nikiteas N; Kouraklis G
    Acta Oncol; 2020 Jan; 59(1):55-59. PubMed ID: 31532272
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients.
    Qin T; Xia J; Liu S; Wang J; Liu H; Zhang Y; Jia Y; Li K
    Thorac Cancer; 2020 May; 11(5):1139-1148. PubMed ID: 32154654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival.
    Pocha K; Mock A; Rapp C; Dettling S; Warta R; Geisenberger C; Jungk C; Martins LR; Grabe N; Reuss D; Debus J; von Deimling A; Abdollahi A; Unterberg A; Herold-Mende CC
    Clin Cancer Res; 2020 May; 26(9):2231-2243. PubMed ID: 31953311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients.
    Wang YY; Li L; Zhao ZS; Wang YX; Ye ZY; Tao HQ
    J Exp Clin Cancer Res; 2013 Sep; 32(1):66. PubMed ID: 24422715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
    Kim M; Chung YS; Kim KA; Shim HS
    Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.
    Tangen IL; Kopperud RK; Visser NC; Staff AC; Tingulstad S; Marcickiewicz J; Amant F; Bjørge L; Pijnenborg JM; Salvesen HB; Werner HM; Trovik J; Krakstad C
    Br J Cancer; 2017 Sep; 117(6):840-847. PubMed ID: 28751757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study.
    Liu ZD; Wang SQ; Li S; He J; Wang SH; Cai HQ; Wan JH
    Clinics (Sao Paulo); 2023; 78():100212. PubMed ID: 37201304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer.
    She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W
    Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
    Hiyoshi Y; Sato Y; Ichinoe M; Nagashio R; Hagiuda D; Kobayashi M; Kusuhara S; Igawa S; Shiomi K; Goshima N; Murakumo Y; Saegusa M; Satoh Y; Masuda N; Naoki K
    Thorac Cancer; 2019 Nov; 10(11):2142-2151. PubMed ID: 31583841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.